Skip to content

SLS - SELLAS Life Sciences Group, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Sellas Life Sciences Group Inc

SLS · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SLSSellas Life Sciences Group Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $15.88
52-wk low: $1.39
Prev close: $8.45
Mkt cap: $2.80B
Beta: 2.49
P/S: 26.9x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$443.4M

MW
Marshall Wace
Q1 2026 13F
$8.6M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in $0.01 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $2.8B

Valuation

P/S26.90
P/B19.22

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SLS
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $2.80B
Beta: 2.49

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

19.2x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-39.6%

$4.6M

position

TS

Two Sigma

Q1 2026 13F

$1.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SLS

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.05-$0.01

-$0.04 expected

Next report

What the street expects next

EPS expected

-$0.06

-$0.06 to -$0.05

Revenue expected

$0.00

1 analysts

Last 30 days

1up1down

Split both ways

-39.6%

ROA-23.3%

Growth

Beta2.49